Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Av. cardiol ; 31(2): 108-115, jun. 2011. ilus, tab
Article in Spanish | LILACS | ID: lil-607760

ABSTRACT

El cierre percutáneo ha aparecido como una alternativa en el tratamiento de la persistencia del conducto arterioso. Presentamos la experiencia en un único centro (Centro Cardiovascular Regional-ASCARDIO-Lara-Venezuela) en el cierre percutáneo de 250 pacientes portadores de la persistencia del conducto arterioso desde octubre 1998 a agosto 2010. La indicación de cierre fue persistencia del conducto arterioso con soplo, sobrecarga de volumen de cavidades izquierdas, sin o con HAP leve a moderada. Se utilizaron 4 tipos de dispositivos: 190 casos con 3 tipos de Amplatzer Duct Ocludder (Tipo 1: 183 casos, Tipo Angulado: 2 casos y Tipo 2: 5 casos), 2 casos con Gianturco coil, 35 casos con Flipper Coil y 23 casos con Duct/Nit-Oclud. En forma global la tasa de éxito de cierre fue 99,6% (249/250), siendo para los 3 dispositivos Amplatzer de 99,4% (189/190), 100% para dispositivo de Gianturco coil (2/2), 100% para dispositivo de Flipper coil (35/35) y 100% para dispositivos Duct/Nit-oclud (23/23), sin shunt residual a las 24 h en 98,8% (247/250) de los casos. Hubo una embolizaciónde dispositivo de Amplatzer tipo 1(1/250=0,4%) que ameritó cirugía y tasa general de complicaciones (menores) fue por debajo del 1% (0,8%), con cero mortalidad. El cierre percutáneo de la persistencia del conducto arterioso ha resultado ser una técnica segura y eficaz con morbilidad mínima y mortalidad cero, en el CCR-Ascardio.


Percutaneous closure has been a new alternative of treatment of persistent ductus arteriosus (PDA). We present our experience in a only Center (Regional Cardiovascular Center-ASCARDIO-Lara-Venezuela) with percutaneous closure in 250 patients with this congenital pathology (isolated persistent ductus arteriosus) since October 1998 until August 2010. Indication for percutaneous closure was all persistent ductus arteriosus with murmur, Diastolic overload of left cavities, without or mild to moderate Pulmonary Hypertension. Four type of devices were used: 190 cases with three types of Amplatzer Duct Ocludder (Type 1: 183 cases, Type angulated or asymmetric: 2 cases and Type 2: 5 cases), Gianturco coil in 2 cases, Flipper coil in 35 cases and Duct/Nit Oclud were used in 23 cases. Overall successful closure rate was 99.6% (249/250), with no 24 hours residual shunt residual in 98.8% (247/250) of cases. According with three types of amplatzer devices, successful closure rate were 99.4% (189/190), 100% for Gianturco coil 2/2, 100% for Flipper Coil (35/35) and 100% for Duct/Nit Oclud (23/23). There was one embolization of amplatzer device type 1(1/250=0.4%) and patient was sent for surgery, and minor complications was less than 1% (0,8%) with no mortality. We can conclude that percutaneous closure of persistent ductus arteriosus is a very safe and secure technique with very low minor complications and with no mortality.


Subject(s)
Humans , Male , Female , Administration, Cutaneous , Congenital Abnormalities/pathology , Congenital Abnormalities/therapy , Ductus Arteriosus , Cardiology
SELECTION OF CITATIONS
SEARCH DETAIL